United States · Wires & real time · Bloomberg

Boehringer, Sino Enter Cancer Drug Deal Worth Over $7 Billion

Published by Bloomberg · United States 1 h ago

Boehringer Ingelheim GmbH signed a licensing deal potentially worth more than $7 billion with China’s Sino Biopharmaceutical Limited and its subsidiaries for experimental cancer…

Read the full article on Bloomberg Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)

Also worth reading

PR Newswire

Energy Fuels Announces Appointment of Jeffrey Olsen to Board of Directors

Associated Press (Business)

Brazil summons Argentina’s representative after Bolsonaro flees to the US via Argentina

Dow Jones Newswires

Rethinking AI in Enterprise Intelligence

MT Newswires

Boehringer, Sino Enter Cancer Drug Deal Worth Over $7 Billion

Share

Also worth reading

Energy Fuels Announces Appointment of Jeffrey Olsen to Board of Directors

Brazil summons Argentina’s representative after Bolsonaro flees to the US via Argentina

Rethinking AI in Enterprise Intelligence

Global Financial News from MT Newswires Now Live in Microsoft Copilot